Novo Nordisk Aktie

47,05 EUR -0,30 EUR -0,63 %

08:14:46

STU

43,35 CHF -0,43 CHF -0,98 %

29.09.2025

BRX

Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.207,35 Mrd. EUR

KGV27,53Div. Rendite1,83%

WKNA3EU6F

ISINDK0062498333

SymbolNONOF

Novo Nordisk Aktien News

Sortieren:Datum Meistgelesen

21.03.24GlobeNewswireAwiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities

21.03.24GlobeNewswireResolutions from the Annual General Meeting of Novo Nordisk A/S

18.03.24GlobeNewswireNovo Nordisk A/S - share repurchase programme

11.03.24GlobeNewswireNovo Nordisk A/S - share repurchase programme

08.03.24GlobeNewswireWegovy® approved in the US for cardiovascular risk reduction in people with overweight or obesity and established cardiovascular disease

07.03.24GlobeNewswireHighlights to be presented at Novo Nordisk’s Capital Markets Day 2024

05.03.24GlobeNewswireNovo Nordisk A/S: Semaglutide 1.0 mg demonstrates 24% reduction in the risk of kidney disease-related events in people with type 2 diabetes and chronic kidney disease in the FLOW trial

04.03.24GlobeNewswireNovo Nordisk A/S - share repurchase programme

26.02.24GlobeNewswireNovo Nordisk A/S - share repurchase programme

21.02.24GlobeNewswireNotice for the Annual General Meeting of Novo Nordisk A/S

19.02.24GlobeNewswireNovo Nordisk A/S – Share repurchase programme

14.02.24GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

12.02.24GlobeNewswireNovo Nordisk A/S - share repurchase programme

12.02.24GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

08.02.24GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

06.02.24GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

06.02.24GlobeNewswireNovo Nordisk A/S - share repurchase programme

05.02.24GlobeNewswireNovo Nordisk to acquire three fill-finish sites from Novo Holdings A/S in connection with the Catalent, Inc. transaction

31.01.24GlobeNewswireNovo Nordisk files annual report with the SEC

31.01.24GlobeNewswireNovo Nordisk's sales increased by 31% in Danish kroner and by 36% at constant exchange rates to DKK 232.3 billion in 2023

30.01.24GlobeNewswireNovo Nordisk A/S - share repurchase programme

22.01.24GlobeNewswireNovo Nordisk A/S - share repurchase programme

15.01.24GlobeNewswireNovo Nordisk A/S - share repurchase programme

09.01.24GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

08.01.24GlobeNewswireCOMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in

08.01.24GlobeNewswireNovo Nordisk A/S - share repurchase programme

04.01.24GlobeNewswireNovo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases

22.12.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

18.12.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

11.12.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

04.12.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

27.11.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

23.11.23GlobeNewswireNovo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France

20.11.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

14.11.23GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

13.11.23GlobeNewswireNovo Nordisk A/S - share repurchase programme

13.11.23GlobeNewswireTrading in Novo Nordisk shares by board members, executives and associated persons

10.11.23GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

10.11.23GlobeNewswireNovo Nordisk invests more than 42 billion Danish kroner in expansion of manufacturing facilities in Kalundborg, Denmark

07.11.23GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Novo Nordisk News

Novo Nordisk News: auf dieser Seite finden Sie alle Novo Nordisk News und Nachrichten zur Novo Nordisk Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novo Nordisk News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novo Nordisk News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.